Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
PRIMARY OBJECTIVE:
To assess feasibility and biodistribution of PET imaging in malignancy using 68Ga-FAPI.
OUTLINE:
Patients receive 68Ga-FAPI intravenously (IV) and then undergo PET/CT approximately 1 hour later.
After completion of study, patients are followed up at 24-72 hours.
Age
19–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient with current malignancy confirmed via pathology or imaging
Patient must be \> 18 years old
Patient must be willing and able to provide written informed consent for the trial
Patient of reproductive potential will have a pregnancy test
You may not be if
Pregnant or breastfeeding
Clareo Health | 68-Ga-FAPI PET Imaging in Malignancy
